As an independent student newspaper and the paper of record for the city of Berkeley, the Daily Cal has been communicating important updates during this pandemic. Your support is essential to maintaining this coverage.
The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
Read More…
CRISPR-Cas9, the gene-editing technology co-invented by a UC Berkeley professor, is again in the courts, as the University of California fights the Broad Institute, Harvard University and the Massachusetts Institute of Technology, or MIT, over patent rights that could yield billions.
Read More…
The Broad Institute filed a brief Wednesday denying many of the University of California’s patent claims on CRISPR-Cas9, a groundbreaking gene editing technology.
Read More…
Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board (PTAB) which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells.
Read More…
The Anna Head Alumnae Hall at UC Berkeley was packed with more than 200 attendees Wednesday evening as Feng Zhang, professor of biomedical engineering at the Massachusetts Institute of Technology and co-discoverer of the CRISPR-Cas9 genome editing technology, spoke on campus about the revolutionary capacities of the biological mechanism.
Read More…
